HHS Secretary Nominee Burwell Pledges To Promote Innovation At FDA
This article was originally published in The Pink Sheet Daily
Executive Summary
In an appearance before the Senate HELP committee, Sylvia Burwell addressed questions on accelerated drug approvals at FDA, the Independent Payment Advisory Board and metrics for enhancing development of new Medicare payment models.